The insurance drug price ceiling for atosiban injection, used to delay pre-term birth in pregnant adult women, will increase.

Currently, three products of atosiban for injection are available. With the drug price ceiling adjustment, better supply is expected following negotiations related to expanding the volume of distribution.

According to the industry on June 11, the drug price ceiling of three products containing atosiban acetate will rise.

Three items include Ferring Korea’s 'Tractocile Inj,' Hanlim Pharm’s 'Trecsiban Inj,' and Dong Kook’s 'Asiban Inj.'

These products are used to delay pre-term birth in pregnant adult women with ▲regular ut